Treace Medical Concepts, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4M | $47.2M | $62.5M | $50.2M | $47.4M | $52.6M | $68.7M | $45.1M |
| Cost of Revenue | $9.8M | $9.8M | $12.1M | $10.5M | $9.6M | $10.7M | $13.2M | $9.0M |
| Gross Profit | $35.6M | $37.4M | $50.4M | $39.7M | $37.8M | $41.9M | $55.5M | $36.1M |
| Gross Margin | 78.5% | 79.3% | 80.6% | 79.1% | 79.7% | 79.7% | 80.7% | 80.1% |
| Operating Expenses | ||||||||
| Research & Development | $4.4M | $4.6M | $4.5M | $4.7M | $5.5M | $5.6M | $5.2M | $5.0M |
| SG&A Expense | $15.2M | $16.2M | $14.5M | $16.3M | $16.1M | $15.8M | $13.6M | $13.5M |
| Operating Income | $-15.0M | $-17.2M | $-5.9M | $-15.7M | $-17.0M | $-15.6M | $-204.0K | $-15.1M |
| Operating Margin | -33.0% | -36.4% | -9.5% | -31.2% | -35.8% | -29.6% | -0.3% | -33.6% |
| Interest Expense | $1.6M | $1.6M | $1.4M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-15.9M | $-18.0M | $-9.4M | $-16.3M | $-17.4M | $-15.9M | $-501.0K | $-15.4M |
| Net Margin | -35.0% | -38.1% | -15.0% | -32.4% | -36.7% | -30.3% | -0.7% | -34.1% |
| EPS (Basic) | $-0.24 | $-0.28 | $-0.14 | $-0.26 | $-0.28 | $-0.25 | $-0.01 | $-0.25 |
| EPS (Diluted) | $-0.24 | $-0.28 | $-0.14 | $-0.26 | $-0.28 | $-0.25 | $-0.01 | $-0.25 |
| Shares Outstanding (Basic) | 65.0M | 64.6M | 63.3M | 63.5M | 63.0M | 62.7M | 62.1M | 62.2M |
| Shares Outstanding (Diluted) | 65.0M | 64.6M | 63.3M | 63.5M | 63.0M | 62.7M | 62.1M | 62.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |